EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Enhancing melanoma therapy with hydrogel microneedles

Lanqi Zhu, Guanlin Qiao, Huiyang Gao, Aowei Jiang, Linan Zhang, Xiaobing Wang

Frontiers in Oncology · 17.04.2025 · 15

DOI: 10.3389/fonc.2025.1590534 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Frontiers in Oncology, online erschienen am 17.04.2025. Verfasst von Lanqi Zhu und 5 weiteren Autor:innen. Beteiligte Einrichtung: The First Clinical Medical College, Shanxi Medical University, Taiyuan, Shanxi, China. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 151 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Melanoma is highly invasive and resistant to conventional treatments, accounting for nearly 75% of skin cancer-related deaths globally. Traditional therapies, such as chemotherapy and immunotherapy, often exhibit limited efficacy and are associated with significant side effects due to systemic drug exposure. Microneedles (MNs), as an emerging drug delivery system, offer multiple advantages, including safety, painlessness, minimal invasiveness, and controlled drug release. Among these, hydrogel microneedles (HMNs) stand out due to their extracellular matrix-like structure and swelling-induced continuous hydrogel channels, which enable the direct delivery of therapeutic agents into the tumor microenvironment (TME). This approach enhances drug bioavailability while reducing systemic toxicity, establishing HMNs as a promising platform for melanoma treatment. This review highlights recent advancements in HMNs for melanoma therapy, focusing on their applications in biomarker extraction for early diagnosis and their role in supporting multimodal treatment strategies, such as chemotherapy, immunotherapy, phototherapy, targeted therapy, and combination therapy. Furthermore, the current matrix materials and fabrication techniques for HMNs are discussed. Finally, the limitations of HMNs in melanoma treatment are critically analyzed, and recommendations for future research and development are provided.

Schlagwörter

Stichwörter der Autor:innen

cancer therapycontrolled releasedrug delivery systemshydrogel microneedlesmelanoma

Autor:innen und Institutionen

  • The First Clinical Medical College, Shanxi Medical University, Taiyuan, Shanxi, China.
  • Department of Plastic and Reconstructive Surgery, First Hospital of Shanxi Medical University, Taiyuan, Shanxi, China.

Zitieren

APA

Zhu, L., Qiao, G., Gao, H., Jiang, A., Zhang, L., & Wang, X. (2025). Enhancing melanoma therapy with hydrogel microneedles. Frontiers in Oncology, 15. https://doi.org/10.3389/fonc.2025.1590534

Vancouver

Zhu L, Qiao G, Gao H, Jiang A, Zhang L, Wang X. Enhancing melanoma therapy with hydrogel microneedles. Frontiers in Oncology. 2025;15. doi:10.3389/fonc.2025.1590534

BibTeX
@article{Zhu2025,
  author = {Zhu, Lanqi and Qiao, Guanlin and Gao, Huiyang and Jiang, Aowei and Zhang, Linan and Wang, Xiaobing},
  title = {Enhancing melanoma therapy with hydrogel microneedles},
  journal = {Frontiers in Oncology},
  year = {2025},
  volume = {15},
  doi = {10.3389/fonc.2025.1590534}
}
Kostenlos starten →